Saint-Gobain completes Florida plant as part of $77m global expansion

Saint-Gobain has completed construction of a tubing plant in Florida, the second of seven manufacturing expansions in its global expansion.

Dan Stanton, Managing editor

November 28, 2019

2 Min Read
Saint-Gobain completes Florida plant as part of $77m global expansion
Image: iStock/metamorworks

French vendor Saint-Gobain has completed construction of a tubing plant in Florida, the second of seven manufacturing expansions intended to support the rapidly growing bioprocess space.

The 80,000 square-foot facility in Largo, Florida is set to increase Saint-Gobain’s manufacturing capacity for its C-Flex tubing and assemblies used in fluid management for biomanufacturing. The plant, which is soon to be operational, has created up to 20 new jobs.

But for Saint-Gobain, the facility completion marks the second part of seven of a three-year expansion period that is seeing the firm invest €70 million ($77 million) to build up its global network.


Image: iStock/metamorworks

The first expansion was at Saint-Gobain’s Bangalore, India site. The firm increased tubing extrusion capabilities at the site through an 11,400 square-foot expansion, operational since September of 2019.

“These are crucial investments for Saint-Gobain Life Sciences as the industry is growing at such a rapid pace,” a spokesperson told us.

Benjamin Le Quéré, general manager Saint-Gobain Bioprocess Solutions said in a statement: “We recognize the responsibility we have to our customers and ultimately, their patients, to increase capacity and localize production, ensuring a reliable, global supply of our products to the Pharmaceutical industry.”

Seven expansions

The other five expansion projects are:

Dublin, Ireland: A 112,000 square-foot expansion will increase production of single-use fluid handling components and systems for high purity applications. Ten jobs will be created and the expansion will be operational this quarter.

Beaverton, Michigan: Operational in Q1 2020, the 87,500 square-foot expansion will be used to make a variety of products, including single-use systems. 60 jobs will be created.

Songdo, South Korea: Following Saint-Gobain’s strategic partnership with CDMO Samsung BioLogics, the firm is constructing a facility nearby making bioprocessing equipment. The site will be operational in Q2 2020.

Charny, France: A 45,700 square-foot expansion, operational in the third quarter 2020, will increase silicone tubing extrusion capabilities.

Hangzhou, China: The seventh facility investment will be at Saint-Gobain’s site in Hangzhou, China but details have not yet been disclosed.

About the Author(s)

Dan Stanton

Managing editor

Journalist covering the international biopharmaceutical manufacturing and processing industries.

Founder and editor of Bioprocess Insider, a daily news offshoot of publication Bioprocess International, with expertise in the pharmaceutical and healthcare sectors, in particular, the following niches: CROs, CDMOs, M&A, IPOs, biotech, bioprocessing methods and equipment, drug delivery, regulatory affairs and business development.

From London, UK originally but currently based in Montpellier, France through a round-a-bout adventure that has seen me live and work in Leeds (UK), London, New Zealand, and China.

You May Also Like